Aptus Capital Advisors’s Pediatrix Medical MD Stock Holding History

Aptus Capital Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-59,474	Closed	-$1.5M	–	491
2019 Q2	$1.5M	Buy	59,474 +13,738	+30%	+$369K	0.21%	88
2019 Q1	$1.24M	Buy	45,736 +8,711	+24%	+$292K	0.21%	103
2018 Q4	$1.22M	Buy	+37,025	New	+$1.49M	0.32%	60

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Aptus Capital Advisors's MD Position: Q3 2019 in Review

Aptus Capital Advisors sold out of Pediatrix Medical (MD) in Q3 2019, closing a stake of 59,474 shares — an estimated $1.5M sold.

Aptus Capital Advisors first reported a position in MD in Q4 2018 and held it in 3 quarters. The position peaked at $1.5M in Q2 2019. 223 funds tracked by Wall St. Rank hold MD as of Q3 2019.

Aptus Capital Advisors reported no remaining Pediatrix Medical position as of Q3 2019 after selling out during the quarter.
Aptus Capital Advisors sold 59,474 Pediatrix Medical shares in Q3 2019, an estimated $1.5M.
Aptus Capital Advisors first reported a position in Pediatrix Medical in Q4 2018 and held it in 3 quarters.
Aptus Capital Advisors's Pediatrix Medical position peaked at $1.5M in Q2 2019.
223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2019.

Based on Aptus Capital Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.